Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant
Status:
Terminated
Trial end date:
2015-10-15
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether cinacalcet, used in patients with secondary
hyperparathyroidism to control excessive parathyroid hormone, can normalize low blood
phosphorus that is commonly seen in patients who have had a kidney transplant.